Torrent Pharmaceuticals is currently trading at Rs. 3526.40, up by 22.05 points or 0.63% from its previous closing of Rs. 3504.35 on the BSE.

The scrip opened at Rs. 3500.05 and has touched a high and low of Rs. 3538.85 and Rs. 3500.05 respectively. So far 3358 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3589.95 on 10-Oct-2024 and a 52 week low of Rs. 2891.45 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs. 3545.00 and Rs. 3314.20 respectively. The current market cap of the company is Rs. 119337.55 crore.

The promoters holding in the company stood at 68.31%, while Institutions and Non-Institutions held 24.66% and 7.03% respectively.

Torrent Pharmaceuticals has sought fair trade regulator -- Competition Commission of India's (CCI) clearance to acquire a majority stake in J B Chemicals and Pharmaceuticals in a Rs 19,500-crore deal. After the completion of the deal, Torrent Pharmaceuticals will become India's second most valued pharma company. The development came after Torrent Pharmaceuticals in June this year announced the acquisition of a majority stake in J B Chemicals and Pharmaceuticals in a Rs 19,500-crore deal.

Torrent Pharmaceuticals (Torrent Pharma) is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.